Sanofi Investors Win Class Cert. In Obesity Drug Suit
A New York federal judge on Wednesday certified a class of Sanofi-Aventis SA investors who claim the French pharmaceutical giant withheld information about anti-obesity drug Zimulti's link to severe psychiatric problems,...To view the full article, register now.
Already a subscriber? Click here to view full article